Abbott Laboratories (ABL.DE) XETRA
Currency In EUR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 217.6B |
| Enterprise Value | 224.14B |
| P/E Ratio | 39.72 |
| PEG Ratio | -0.6 |
| Price/Sales Ratio | 3.85 |
| Price/Book Ratio | 3.65 |
| Enterprise/Revenue | 4.41 |
| Enterprise/EBITDA | 19.23 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
Profitability
| Profit Margin | 0.1 |
| Operating Margin | 0.15 |
AD
Management Effectiveness
| Return On Assets | 0.04 |
| Return On Equity | 0.09 |
Income Statement
| Revenue | 44.33B |
| Revenue/Share | 27.81 |
| Gross Profit | 25.22B |
| EBITDA | 11.38B |
| Net Income | 6.52B |
| Diluted EPS | 3.73 |
Balance Sheet
| Total Cash | 4.3B |
| Total Cash/Share | 2.48 |
| Total Debt | 31.16B |
| Total Debt/Equity | 0.61 |
| Current Ratio | 1.45 |
| Book Value Per Share | 29.76 |
Price History
| 52-Week Change | -11.32 |
| 52-Week High | 113.36 |
| 52-Week Low | 70.1 |
| Moving Average 50 Days | 91.78 |
| Moving Average 200 Days | 87.88 |
Statistics
| Average Volume | 824 |
| Shares Outstanding | 1.73B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2.52 |
| Trailing Annual Dividend Yield | 2.35 |
| Payout Ratio | 0.92 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
